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Abstract
Background:  Improving immunisation rates in risk groups is one of the main objectives in
vaccination strategies. However, achieving high vaccination rates in children with chronic
conditions is difficult. Different types of vaccine providers may differently attract high risk children.
Aim: To describe the characteristics of two populations of children who attended a private and a
public immunisation provider in the same area. Secondarily, to determine if prevalence of patients
with underlying diseases by type of provider differs and to study if the choice of different providers
influences timeliness in immunisation.
Methods: We performed a cross-sectional study on parents of children 2 – 36 months of age who
attended a private hospital immunisation service or a public immunisation office serving the same
metropolitan area of Rome, Italy. Data on personal characteristics and immunisation history were
collected through a face to face interview with parents of vaccinees, and compared by type of
provider. Prevalence of underlying conditions was compared in the two populations. Timeliness in
immunisation and its determinants were analysed through a logistic regression model.
Results: A total of 202 parents of children 2–36 months of age were interviewed; 104 were in the
public office, and 98 in the hospital practice. Children immunised in the hospital were more
frequently firstborn female children, breast fed for a longer period, with a lower birthweight, and
more frequently with a previous hospitalisation. The prevalence of high risk children immunised in
the hospital was 9.2 vs 0% in the public service (P = 0.001). Immunisation delay for due vaccines
was higher in the hospital practice than in the public service (DTP, polio, HBV, and Hib: 39.8% vs
22.1%; P = 0.005). Anyway multivariate analyses did not reveal differences in timeliness between
the public and private hospital settings.
Conclusion:  Children with underlying diseases or a low birthweight were more frequently
immunised in the hospital. This finding suggests that offering immunisations in a hospital setting may
facilitate vaccination uptake in high risk groups. An integration between public and hospital
practices and an effort to improve communication on vaccines to parents, may significantly increase
immunisation rates in high risk groups and in the general population, and prevent immunisation
delays.
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Background
The control of vaccine preventable diseases is one of the
major advances of public health [1]. Although immunisa-
tion uptake is high for most routine immunisations in
western countries, yet high risk groups, including children
with underlying diseases, have often low immunisation
coverage [1]. Chronic diseases such as neurological and
cardiovascular disorders are associated with high hospital-
isation rates [2,3], and some immunisations including
influenza and conjugate pneumococcal vaccines may pre-
vent admission into hospital, medical visits, and other
negative effects in these patients [4,5]. Despite mathemat-
ical models suggest that focusing immunisations on high
risk groups may be suitable [6,7], parents of children at
risk may underestimate incidence and severity of vaccine
preventable diseases and may not be appropriately
informed about safety and efficacy of available vaccines
[7-10]. Moreover immunisation delays often occur
because of false contraindications linked to an underlying
condition that, on the contrary, may represent an indica-
tion to immunisation [10-12]. Immunisation rates are
usually monitored by immunisation registries [13]; in the
U.S. vaccine delivery is shifting from the public sector to
the private sector, with an emphasis on vaccination in the
context of primary care and the medical home [14].
Patients with chronic diseases may refer to private provid-
ers, that often do not submit data to a national or regional
registry [13,15]. The reasons leading parents to choose a
private practice for immunisation have not been well
studied yet. This study aims, primarily, to describe the
characteristics of two populations attending a private or a
public immunisation service in the same metropolitan
area. Secondarily this study has the objective to determine
if the prevalence of patients with chronic diseases by type
of service differs, and to study if the choice of different
providers is associated with timeliness in immunisation.
Methods
Background on local immunization policies
In Italy immunisations against diphtheria, tetanus, per-
tussis, hepatitis B, poliomyelitis, Haemophilus influenzae
type b, mumps-measles-rubella are universally offered to
all infants [16]. Children with underlying diseases are rec-
ommended to receive influenza, pneumococcal, menin-
gococcal and varicella vaccines [17,18]. A national survey
performed in 2003 showed that immunisation coverage
within 24 months of age for influenza, pneumococcal,
and varicella vaccines was less than 3% in the general pop-
ulation, and less than 10% in high risk groups [19,20].
Most immunisations are delivered in Italy by the public
health service while private immunisation practices
administer nearly 3% of all vaccines with wide differences
among Regions [20].
The national immunisation schedule includes: three
doses of DTaP, Polio (IPV), HepB, Hib in the first year of
life; a first dose of MMR between the 12th and the 14th
month; a second dose of MMR at 5 years of age. Conjugate
pneumococcal, conjugate meningococcal C, and varicella
vaccines are recommended at national level for selected
risk groups only.
Setting
We conducted the present study in a private paediatric
research hospital with nearly 400 beds, and in a public
immunisation service in the same area. The two facilities
offer the same immunisations with the same schedule but
with different charges for families (Table 1).
Study design
We performed a cross-sectional study on parents of chil-
dren 2 – 36 months of age in a private hospital immuni-
sation service attended by outpatients or to a public
immunisation office serving the same metropolitan area
of Rome, Italy, with approximately 53.000 inhabitants.
One interviewer (EP) visited the two practices two days a
week during office hours, and systematically performed a
face to face interview to parents of vaccinees from January
to July 2006 until reaching the desired sample size (Figure
1; Figure 2).
A questionnaire including information on children
immunisation history, the reasons for delay or incom-
plete immunisation, and the reasons for choosing a pub-
lic or a private hospital service, was administered to
parents before the child was immunised after obtaining
informed consent.
Table 1: Comparison of the immunisation services included in the study.
Public immunisation service Hospital provider
Approximate average number of immunisations per year 50.000 3.000
DTaP, Polio, Hib, HepB Free Fully charged
Pneumococcal conjugate vaccine Copayment Fully charged
Meningococcal C conjugate vaccine Copayment Fully charged
Influenza vaccine Copayment Fully charged
Varicella vaccine Copayment Fully chargedBMC Public Health 2008, 8:278 http://www.biomedcentral.com/1471-2458/8/278
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Co-operation rate of parents to the interview in the public immunization service Figure 1
Co-operation rate of parents to the interview in the public immunization service.
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Co-operation rate of parents to the interview in the Pediatric hospital Figure 2
Co-operation rate of parents to the interview in the Pediatric hospital.
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Definitions
For influenza vaccine, coverage was calculated as the pro-
portion of children older than 6 months who had received
at least one dose in the past season. For conjugate pneu-
mococcal and meningococcal C vaccines, coverage was
the proportion of children older than three months who
received at least one dose of vaccine. For varicella vaccine,
coverage was the proportion of children older than 12
months who ever received at least one dose of vaccine.
Delay in immunisations was defined for DTP, Polio, HBV
and Hib as: a) first dose received later than 105 days of
age; OR b) second dose received later than 70 days after
the first dose; OR c) third dose received after 380 days of
age. For MMR and varicella delay was defined as an
immunisation after the 15th month of age. These time
intervals were calculated according to national recom-
mendations for vaccine administration [20].
Sample size
The sample size was calculated to detect a difference in the
prevalence of high risk children in the two settings.
Assuming a prevalence rate of children with underlying
diseases of 3% in the general population [19] and a risk
ratio of 5, a total population of 200 children (100 per
group) was considered sufficient to detect a difference in
prevalence between those observed in the public and in
the hospital practice with a power of 80% and a level of
significance of 5%.
Analysis
Chi square or Fisher exact test for categorical variables and
the Student's t test for continuous variables were used for
assessing statistical significance at the univariate level. A
logistic regression model was used to asses the role of dif-
ferent variables as determinants of timeliness in immuni-
sation. Odds ratios and their 95% confidence intervals
were used as measures of effect in the logistic regression
model.
Results
A total of 202 parents of children 2–36 months of age
were interviewed, 104 (51.5%) in the public office, and
98 (48.5%) in the hospital practice. (Figure 1a,1b).
The general features of parents interviewed and their chil-
dren in the two groups are shown in Table 2.
Although several characteristics of parents and children
seen in the two practices were similar, foreign parents and
graduated mothers were more represented in families who
requested immunisation in the public service, whereas
families interviewed in the hospital practice had more fre-
quently firstborn female children to be vaccinated, who
were breast fed for a longer period, who had a lower birth
weight, and who were more frequently hospitalised in the
previous period.
The overall immunisation coverage for influenza vaccine
was 1.9% (2 patients) in children in the public office and
1.0% (1 patient) in those immunised in the hospital prac-
tice (P = 0.52). Immunisation with conjugate pneumococ-
cal vaccine was administered to 70 (67.3%) children in
the public practice and 63 (64.0%) in the hospital office
(P = 0.65), whereas 59 (56.7%) of them in public service
and 49 (50.0%) in hospital office were immunised with
conjugate meningococcal C vaccine (P = 0.33). Finally,
none of the children in the public practice and 5 (5.10%)
Table 2: Characteristics of vaccinees and their families recorded by type of practice
Public immunisation service 
(N = 104)
Hospital provider (N = 98) Total (N = 202) P-value
Mother's mean age, years (range) 34.7 (19 – 47) 34.7 (24 – 45) 34.7 (19–47) 0.96
Mother from foreign country, n (%) 17 (16.3%) 7 (7.2%) 24 (11.9%) 0.04
Graduated mother, n (%) 59 (56.7%) 40 (41.2%) 99 (49.2%) 0.03
Working mother, n (%) 75 (72.1%) 67 (69.0%) 142 (70.3%) 0.04
Father's mean age, years (range) 37.3 (26 – 52) 37.8 (23 – 63) 37.6 (23–63) 0.48
Father from foreign country, n (%) 13 (12.5%) 5 (5.1%) 18 (8.9%) 0.06
Graduated father, n (%) 47 (45.2%) 37 (37.7%) 84 (41.6%) 0.30
Working father, n (%) 103 (99%) 96 (97.9%) 199 (98.5%) 0.50
Children age, months, mean (range) 9.8 (2–22) 11.8 (2–35) 10.8 (2–35) 0.02
Male children, n (%) 62 (59,6%) 40 (40.8%) 102 (50.5%) 0.008
Firstborn child, n (%) 56 (53.8%) 69 (70.4%) 125 (61.9%) 0.01
No. of households, mean (range) 3.5 (2 – 5) 3.4 (2–6) 3.5 (2–6) 0.50
Children with Previous hospitalisations 
(%)
15 (14.4%) 23 (23.7%) 38 (18.8%) 0.09
Birthweight, g, mean (range) 3270.0(1500–4400) 3065.0(1180 – 4500) 3170 (1180–4500) 0.01
Breast feeding duration, months, mean 
(range)
4.21 (0 – 15) 5.3 (0 – 14) 4.7 (0–15) 0.04BMC Public Health 2008, 8:278 http://www.biomedcentral.com/1471-2458/8/278
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in the hospital office were immunised against varicella
vaccine (P = 0.02)
Nine (9.2%) out of the 98 patients immunised in the hos-
pital had an underlying disease which was an indication
for influenza, pneumococcal, and meningococcal C
immunisation. Out of them only 1 child was immunised
against influenza; 6 against pneumococcus, and 4 against
meningococcus C at the time of the interview. Underlying
diseases included: three cases of congenital heart disease,
two cases of a neurological disease, and one case of a
genetic syndrome. None of the children immunised in the
public service had an underlying disease (P = 0.001).
The Italian Ministry of Health also recommends influenza
immunisation of households of patients belonging to risk
groups [20]. Among the parents of these children only 2/
9 mothers and 4/9 fathers received influenza immunisa-
tion.
Although the number of children with an immunisation
delay was substantial in both practices, they were nearly
twice in the hospital practice than in the public service
(DTP, polio, HBV, and Hib: 39.8% vs 22.1%; P = 0.005;
MMR: 20.0% vs 12.5%; P = 0.15). Causes of delayed or
missing immunisation reported from parents were mostly
related to misinformation (58%), and child illness
(15.6%).
Determinants of delayed immunisation was studied
through a logistic regression model (Table 3). The univar-
iate analysis showed that a lower education of parents, a
low birth weight, and immunisation in the hospital pre-
dicted an immunisation delay, but none of these variables
were significant in the multivariate model. None of the
variables included in the analysis were associated as well
with delay of MMR immunisation, while children with a
father from a foreign country were more likely to receive
pneumococcal immunisation (OR: 3.18; 95% CI: 1.08 –
9.42).
The most frequent reason for choosing the hospital service
was that parents felt safe in a hospital environment
(39%). On the other hand parents whose children were
immunised in the public service felt that the office was
easy to reach (20.2%) or were advised by the family pae-
diatrician (19.2%).
Even if a higher proportion of children with chronic con-
ditions requiring immunisation in the hospital was
expected, it should be noted that 38% of families inter-
viewed in the hospital service had previously visited a
public office for immunisation and 38% of their children
were not immunised due to a false contraindication, that
most of all was represented by the child's underlying dis-
ease. Another reason for attending the hospital practice
was unavailability of some vaccines due to a temporary
shortage of Meningococcal, Pneumococcal or Varicella
vaccines, because of their different policies compared with
universally recommended vaccines. Finally 8% of chil-
dren immunised in the hospital had previous contacts
with the same hospital.
Discussion and conclusion
This study shows that children with underlying diseases,
which often represent an indication to certain immunisa-
tions, were more likely to attend the hospital immunisa-
Table 3: Likelihood of on-time vaccination (multivariate analysis results are reported only for those variables who resulted significant 
at the univariate analysis)
DTP, HBV, POLIO, Hib
Univariate analysis, OR (95% CI) Multivariate analysis, OR (95% CI)
Mother's age < 30 yrs 0.52 (0.22–1.24)
Mother from foreign country 1.17 (0.43–3.13)
Mother degree 0.46 (0.24–0.90) 1.387 (0.662;2.903)
Working mother 0.88 (0.44–1.79)
Father's age 0.29 (0.08–1.01)
Father from foreign country 0.86 (0.25–2.75)
Father degree 0.41 (0.20–0.82) 2.102 (0.963;4.589)
Working father 0.22 (0.01–3.11)
Child age < 12 months 0.74 (0.40–1.34)
Vaccinee's male gender 0.97 (0.51–1.85)
Child with previous hospitalization 2.19 (1.00–4.81) 1.757 (0.823;3.750)
Child birthweight < 2500 gr 0.41 (0.14–1.13) 1.000 (1.000;1.001)
Child breastfeeding duration < 6 months 0.79 (0.38–1.65)
Firstborn child 1.44 (0.73–2.85)
Private immunisation office 2.32 (1.22–4.54)BMC Public Health 2008, 8:278 http://www.biomedcentral.com/1471-2458/8/278
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tion provider rather than the public office of their own
district.
Families of children with low birth weight preferred more
often immunisation in the hospital and were more likely
to be immunised against influenza. Parents who chose to
immunise their children in the hospital have the percep-
tion of hospital as a safer environment; this finding
underlines how lack of information or misinformation
and the perception of an underlying disease as a contrain-
dication, play a substantial role in the choice of health
care providers and inappropriate consultation.
Despite recommendations in place, coverage for immuni-
sations indicated in high risk groups is low in our country
[18,19]. Other studies performed in hospital settings and
on high risk group children showed that immunisation
coverage among these groups remains low and immunisa-
tions are often delayed. [21-28].
We found that families of children with immunisation
delay attending the hospital practice had often previously
attempted to vaccinate their children. This observation
underlines the potential to improve immunisation timeli-
ness through simple information and educational activi-
ties.
Different approaches have been proposed for overcoming
immunisation barriers in high risk groups. There is evi-
dence that enhanced information focusing on vaccines
benefits and how to manage their potential adverse
effects, increased availability of vaccine offices, use of
missed opportunities, and gratuity of immunisation are
efficacious in increasing immunisation uptake [11-13].
We also observed that being immunised in a hospital set-
ting was a predictor of delayed immunisation for routine
vaccines. We speculate that this finding may be associated
with misinformation and false contraindications, and it is
in line with the frequent parents' perception of hospital as
a safe environment.
Regarding the determinants of appropriateness of immu-
nisation we did not find significant associations with any
of the variables included in the analysis. However the
study may have not been adequately powered to address
this issue. Nevertheless, we found a signal toward an asso-
ciation between an higher education of parents and time-
liness of immunisation.
Although the number of vaccinees may be small in a pri-
vate hospital practice, this finding underlines how offer-
ing immunisations indicated in high risk groups in a
hospital setting may result in a significant benefit. Hospi-
tals are likely to attract high risk groups which often are
immunised late.
One advantage of this study was the inclusion of different
immunisation settings serving the same population
although these results are not necessarily generalizable to
other settings. Our findings show that an integration
between public and hospital settings, and an effort to
improve communication on vaccines to parents, may sig-
nificantly increase immunisation rates in high risk groups
and in the general population and prevent the delays in
immunisation.
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